Sara joined Royalty Pharma in 2012. Previously, Sara was an analyst in the Healthcare Investment Banking group at Goldman Sachs & Co. Sara has a BSBA and BA in molecular, cellular and developmental biology from the University of Colorado at Boulder.
Sara joined Royalty Pharma in 2012. Previously, Sara was an analyst in the Healthcare Investment Banking group at Goldman Sachs & Co. Sara has a BSBA and BA in molecular, cellular and developmental biology from the University of Colorado at Boulder.
